{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:27:53Z","timestamp":1778628473580,"version":"3.51.4"},"reference-count":33,"publisher":"Informa Healthcare","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1517\/14656566.6.12.2091","type":"journal-article","created":{"date-parts":[[2005,10,3]],"date-time":"2005-10-03T08:16:53Z","timestamp":1128327413000},"page":"2091-2101","source":"Crossref","is-referenced-by-count":89,"title":["Aripiprazole"],"prefix":"10.1517","volume":"6","author":[{"given":"W Wolfgang","family":"Fleischhacker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,10,3]]},"reference":[{"key":"CIT0002","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2165\/00003495-200464150-00010","volume":"64","author":"SWAINSTON-HARRISON TS","year":"2004","journal-title":"Drugs"},{"key":"CIT0003","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2165\/00023210-200216110-00008","volume":"16","author":"MCGAVIN JK","year":"2002","journal-title":"CNS Drugs"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","volume":"20","author":"LAWLER C","year":"1999","journal-title":"Neuropsychopharmaco\/ogy"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.033175"},{"key":"CIT0008","first-page":"45","volume":"483","author":"JORDAN S","year":"2004","journal-title":"V DUNN R et al.: In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function. Eur. j PharmacoL"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003261901"},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/0091270004269870","volume":"45","author":"CITROME L","year":"2005","journal-title":"Clin. PharmacoL"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0903"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00050-1","volume":"61","author":"MARDER SR","year":"2003","journal-title":"Schizophrenia Res."},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.60.7.681"},{"key":"CIT0027","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-002-1344-3","volume":"166","author":"CASEY DA","year":"2003","journal-title":"Psychopharmacology"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0910"},{"key":"CIT0029","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1461145703003651","volume":"6","author":"KASPER S","year":"2003","journal-title":"Int. J. Neuropsychopharmacol"},{"key":"CIT0033","first-page":"1268","volume":"42","author":"LINDSEY RI","year":"2003","journal-title":"KOLIATSOS V et al.: Ariprazole and extrapyramidal symptoms. J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"CIT0034","first-page":"114","volume":"2004","author":"SCHONBERGER RB","year":"1743","journal-title":"Pediatrics"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/070674370304801116","volume":"48","author":"DUGGAL HS","year":"2003","journal-title":"Can. J. Psychiatry"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.5.522.33352"},{"key":"CIT0037","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.chi.0000142277.95052.94","volume":"43","author":"SPALDING S","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00004850-200411000-00007","volume":"19","author":"CHAKRABORTY N","year":"2004","journal-title":"Int. Clin. Psychopharmacol."},{"key":"CIT0040","first-page":"596","volume":"27","author":"AMERICAN DIABETES ASSOCIATION, AMERICAN PSYCHIATRIC ASSOCIATION, AMERICAN","year":"2004","journal-title":"Consensus development conference on antipsychotic drugs, obesity and diabetes. Diabetes Care"},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-200565020-00006","volume":"65","author":"BERK M","year":"2005","journal-title":"Drugs"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1651"},{"key":"CIT0044","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","volume":"187","author":"VIETA E","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"CIT0050","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/01.jcp.0000178415.22309.8f","volume":"25","author":"DE DEYN P","year":"2005","journal-title":"J. Clin. Psychopharmacol."},{"key":"CIT0051","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4088\/PCC.v06n0112","volume":"6","author":"GUPTA S","year":"2004","journal-title":"Prim. Care Companion Clin. Psychiatry"},{"key":"CIT0052","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1176\/appi.ajp.161.2.373-a","volume":"161","author":"SCHDNFELDT-LECUONA C","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"CIT0053","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00002826-200401000-00003","volume":"27","author":"FERNANDEZ HH","year":"2004","journal-title":"Clin. NeuropharmacoL"},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1345\/aph.1D147","volume":"37","author":"STALLER JA","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"CIT0056","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/01.chi.0000132834.43268.10","volume":"43","author":"MYERS WC","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000139759.03834.e4"},{"key":"CIT0058","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00004850-200501000-00002","volume":"20","author":"WORTHINGTON JJ III, KINRYS G, WYGANT LE et al.","year":"2005","journal-title":"Int. Clin. PychopharmacoL"},{"issue":"1","key":"CIT0059","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2004.11.007","volume":"86","author":"ADSON DE","year":"2005","journal-title":"J. Affect. Disord."},{"key":"CIT0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/070674370404900213","volume":"49","author":"DUGGAL HS","year":"2004","journal-title":"Can. J. Psychiatry"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.6.12.2091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T17:26:57Z","timestamp":1553621217000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.6.12.2091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2005,10,3]]},"published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1517\/14656566.6.12.2091"],"URL":"https:\/\/doi.org\/10.1517\/14656566.6.12.2091","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}